Literature DB >> 20607537

Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population.

Colm Keane, Peter Mollee, Paula Marlton, Devinder Gill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20607537     DOI： 10.1007/s00277-010-1023-0

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  3 in total

Review 1.  Reflections on Cultural Preferences and Internal Medicine: The Case of Jehovah's Witnesses and the Changing Thresholds for Blood Transfusions.

Authors:  Iftach Sagy; Alan Jotkowitz; Leonid Barski
Journal:  J Relig Health       Date:  2017-04

2.  Cutoff values of serum ferritin and TIBC saturation for the evaluation of gastrointestinal neoplasms in adult anemic patients.

Authors:  Mark Hong Lee; Eugene Park; Jongchan Lee; So Young Kim; Sung Yong Kim; Sun Young Lee; Yo Han Cho; So Young Yoon
Journal:  Int J Hematol       Date:  2012-06-28       Impact factor: 2.490

3.  Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation.

Authors:  Anand P Jillella; Martha L Arellano; Leonard T Heffner; Manila Gaddh; Amelia A Langston; Hanna J Khoury; Abhishek Mangoankar; Vamsi K Kota
Journal:  Hematol Rep       Date:  2017-09-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.